Lena N - Search Results

1

[Control of the toxicity of high-dose methotrexate by pharmacokinetic surveillance].

Favre R, Pignon T, Lena N, Cano JP, Carcassonne Y. Favre R, et al. Among authors: lena n. Presse Med. 1983 Oct 29;12(38):2400. Presse Med. 1983. PMID: 6227000 French. No abstract available.

2

Methotrexate test-dose protocol in the presence of 7-hydroxy-methotrexate.

Lena N, Imbert AM, Favre R, Cano JP, Carcassonne Y. Lena N, et al. Eur J Cancer Clin Oncol. 1987 May;23(5):481-5. doi: 10.1016/0277-5379(87)90307-5. Eur J Cancer Clin Oncol. 1987. PMID: 3477455

3

Methotrexate and 7-hydroxy-methotrexate pharmacokinetics following intravenous bolus administration and high-dose infusion of methotrexate.

Bore P, Bruno R, Lena N, Favre R, Cano JP. Bore P, et al. Among authors: lena n. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1385-90. doi: 10.1016/0277-5379(87)90124-6. Eur J Cancer Clin Oncol. 1987. PMID: 3500051 Clinical Trial.

4

Dosage predictions in high-dose methotrexate infusions. Part 1: Evaluation of the classic test-dose protocol.

Cano JP, Bruno R, Lena N, Favre R, Iliadis A, Imbert AM. Cano JP, et al. Among authors: lena n. Cancer Drug Deliv. 1985 Fall;2(4):271-6. doi: 10.1089/cdd.1985.2.271. Cancer Drug Deliv. 1985. PMID: 3864520

5

Dosage predictions in high-dose methotrexate infusions. Part 2: Bayesian estimation of methotrexate clearance.

Bruno R, Iliadis A, Favre R, Lena N, Imbert AM, Cano JP. Bruno R, et al. Among authors: lena n. Cancer Drug Deliv. 1985 Fall;2(4):277-83. doi: 10.1089/cdd.1985.2.277. Cancer Drug Deliv. 1985. PMID: 4063950

6

Methotrexate-vindesine association in the treatment of head and neck cancer influence of vindesine on methotrexate's pharmacokinetic behavior.

Lena N, Imbert AM, Pignon T, Favre R, Meyer G, Cano JP, Carcassonne Y. Lena N, et al. Cancer Chemother Pharmacol. 1984;12(2):120-4. doi: 10.1007/BF00254603. Cancer Chemother Pharmacol. 1984. PMID: 6697425

7

High-dose methotrexate: a clinical and pharmacokinetic evaluation. Treatment of advanced squamous cell carcinoma of the head and neck using a prospective mathematical model and pharmacokinetic surveillance.

Favre R, Monjanel S, Alfonsi M, Pradoura JP, Bagarry-Liegey D, Clement S, Imbert AM, Lena N, Colonna d'Istria J, Cano JP, Carcassonne Y. Favre R, et al. Among authors: lena n. Cancer Chemother Pharmacol. 1982;9(3):156-60. doi: 10.1007/BF00257744. Cancer Chemother Pharmacol. 1982. PMID: 7160050

8

Kinetics of methotrexate and its metabolites in red blood cells.

Lena N, Imbert AM, Brunet P, Cano JP, Carcassonne Y. Lena N, et al. Cancer Drug Deliv. 1987;4(2):119-27. doi: 10.1089/cdd.1987.4.119. Cancer Drug Deliv. 1987. PMID: 2448023

9

Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesine.

Bore P, Lena N, Imbert AM, Favre R, Cano JP, Meyer G, Carcassonne Y. Bore P, et al. Among authors: lena n. Cancer Chemother Pharmacol. 1986;17(2):171-6. doi: 10.1007/BF00306749. Cancer Chemother Pharmacol. 1986. PMID: 3719898

10

Methotrexate-vindesine association in leukemia: pharmacokinetic study.

Tubiana N, Lena N, Barbet J, Imbert AM, Lejeune C, Maraninchi D, Sainty D, Sebahoun G, Gastaut JA, Cano JP, et al. Tubiana N, et al. Among authors: lena n. Med Oncol Tumor Pharmacother. 1985;2(2):99-102. doi: 10.1007/BF02934855. Med Oncol Tumor Pharmacother. 1985. PMID: 3864001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters